Eszopiclone Tablet, Film Coated
Product Images NDC 80425-0168

4 FDA label images from Advanced Rx Pharmacy Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 80425-0168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Eszopiclone, showing its molecular arrangement including nitrogen, oxygen, chlorine atoms, and ring structures characteristic of this active ingredient.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Eszopiclone 1 mg film-coated tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20-25°C), a barcode, lot number 60ESZ11123, expiration date 11/30/2023, and references to MACLEODS PHARMA. It mentions the drug schedule as C-IV and the product NDC as 80425-0168.*
FDA Label Image

Lable 2 (Eszopiclone 80425 0168 02)

Lable 2 (Eszopiclone 80425 0168 02)
Eszopiclone 1 mg film-coated tablets packaging label showing the proprietary name Eszopiclone, strength 1 mg, quantity of 90 tablets. The label includes storage instructions (20-25°C), a comparison statement to Lunesta, NDC 80425-0168-03, lot and expiration date fields, manufacturer Macleods Pharma, and is labeled by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN.*
FDA Label Image

Label 3 (Eszopiclone 1mg 80425 0168 01)

Label 3 (Eszopiclone 1mg 80425 0168 01)
Eszopiclone 1 mg film-coated tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions, lot number, expiration date (3/31/2024), and a comparison to Lunesta. The package count is 30 tablets. The label also shows the product NDC 80425-0168-01 and marks the drug as a Schedule IV controlled substance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.